p.e of about 30 is a good reason over priced plus comming into the better part of the year the result wasn't all that good in my book
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025